Herceptin injection 150, manufactured by Chugai Pharmaceutical, contains Trastuzumab (genetical recombination), a biologic cancer treatment that targets the HER2 protein to inhibit cancer cell growth. It is used for HER2-positive breast, gastric, and salivary gland cancers, supplied as 150mg 1 bottle, with YJ code 4291406D6020.
Herceptin injection 150
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →